Sheila E. Crowe, MD, AGAF, chair of the nominating committee, is pleased to announce that John M. Inadomi, MD, AGAF, joins the presidential line up for AGA.
John M. Inadomi, MD, AGAF
Dr. Inadomi is a national expert in comparative effectiveness research and colorectal cancer who has lent his expertise to AGA in several capacities over the years, most recently as the clinical research councillor to the board. Dr. Inadomi will serve as vice president, then president elect and will become AGA president after Digestive Disease Week® (DDW) 2021.
The AGA Nominating Committee also appointed the following slate of councillors, which is subject to membership vote.
Maria T. Abreu, MD, AGAF
Councillor-At-Large: Maria T. Abreu, MD, AGAF, is former chair of the AGA Institute Council, which plans AGA’s programming for DDW, and a researcher and clinician focusing on inflammatory bowel disease (IBD), microbiome and colorectal cancer.
David A. Katzka, MD
Education and Training Councillor: David A. Katzka, MD, has been very active in AGA’s education and practice initiatives, including his recently completed service as the chair of the AGA Institute Clinical Practice Updates Committee. Dr. Katzka received AGA’s distinguished clinician award in 2010. His research and clinical work focus on esophageal disorders.
Michael L. Kochman, MD, AGAF
Councillor-at-Large, Growth and Development: Michael L. Kochman, MD, AGAF, takes on this newly created governing board position after successfully leading the AGA Center for GI Innovation and Technology. He is an interventional endoscopist at University of Pennsylvania.
Pending approval by the voting membership, all board members begin their terms after DDW 2019. The voting membership will be sent a ballot to approve the slate of officers on or before March 21, 2019, with a response date of no later than April 20, 2019.
Thank you to our nominating committee members, pictured here at a well-deserved dinner after their committee work was completed.